Pharma Giant Novartis Explores Agency Options

Inspiration meets innovation at Brandweek, the ultimate marketing experience. Join industry luminaries, rising talent and strategic experts in Phoenix, Arizona this September 23–26 to assess challenges, develop solutions and create new pathways for growth. Register early to save.

Novartis is talking to agency search consultants about global media duties on its ad account, according to sources.

Sources familiar with the client’s deliberations say that the pharmaceuticals giant is exploring its options but has yet to sign off on a review.

A Novartis rep at the company’s headquarters in Basel, Switzerland, said “We won’t comment on rumors,” via e-mail.

The incumbent on the account is WPP’s MEC. Officials there didn’t return calls.

The client is said to be spending approximately $600 million a year on ads worldwide, down about a third from just a few years ago, when it reportedly spent around $950 million globally.

AW+

WORK SMARTER - LEARN, GROW AND BE INSPIRED.

Subscribe today!

To Read the Full Story Become an Adweek+ Subscriber

View Subscription Options

Already a member? Sign in